CIK 0001572616 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
FRACTYL HEALTH, INC.
Sign in to watch- Ticker
- GUTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273553477
- Phone
- 781-902-8800
- Business address
- 3 VAN DE GRAAFF DRIVE, SUITE 200, BURLINGTON, MA, 01803
- Former names
- Fractyl Laboratories Inc.
- Open-market buys, last 90 days
- $39,903
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$39,903. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-14 | BRADLEY WILLIAM Director | Purchase | +64,516 | $0.62 | $40K | 149,138 |
| 2026-06-12 | Royan Ajay Director | Purchase | +23,000 | $0.85 | $20K | 40,901 |
| 2026-06-10 | BRADLEY WILLIAM Director | Purchase | +68,493 | $0.73 | $50K | 84,622 |
| 2026-06-10 | BRADLEY WILLIAM Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Conaway Samuel Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Royan Ajay Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Thompson Christopher Charles Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Elia Marc Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Barnes Kelly Ann Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | MEANWELL CLIVE Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Sheffield Ian Director | Purchase | +35,000 | $0.73 | $26K | 35,000 |
| 2026-06-10 | Sheffield Ian Director | Grant or award · Stock Option | +22,500 | 22,500 | ||
| 2026-06-10 | Rajagopalan Harith Chief Executive Officer | Purchase | +25,000 | $0.73 | $18K | 540,557 |
| 2026-06-08 | Smith Weber Lara Chief Financial Officer | Purchase | +20,000 | $0.69 | $14K | 20,000 |
| 2026-01-12 | Smith Weber Lara Chief Financial Officer | Grant or award · Stock Option | +1,036,800 | 1,036,800 | ||
| 2025-12-15 | Toomey Sarah General Counsel | Grant or award · Stock Option (right to buy) | +743,913 | 743,913 | ||
| 2025-12-15 | Caplan Jay David President, Chief Product Off. | Grant or award · Stock Option (right to buy) | +845,226 | 845,226 | ||
| 2025-12-15 | Rajagopalan Harith Chief Executive Officer | Grant or award · Stock Option (right to buy) | +2,486,302 | 2,486,302 | ||
| 2025-12-04 | Rajagopalan Harith Chief Executive Officer | Purchase | +10,416 | $1.92 | $20K | 501,745 |
| 2025-09-02 | Thompson Christopher Charles Director | Grant or award · Stock Option | +45,000 | 45,000 |
Page 1 of 8 · 154 trades